The Latest Breaking News from Pfizer

Pfizer is in early talks to acquire cancer specialist Seagen, according to a report that sent SGEN stock flying on Monday.

Pfizer (PFE) reported record-breaking revenue and earnings for fiscal 2022. Furthermore, the combination of expected launches and additional pipeline products position the company for continued robust growth through the rest of this decade and beyond. Amid a volatile macro environment, investing in this high-value stock for the long term could…

Here's a quick wrap of the COVID-19 news and case numbers from each Australian jurisdiction from the past week.

A resilient economy and sticky inflation could lead Fed officials to hike interest rates higher than anticipated in the central bank’s next meeting. Although markets have been highly volatile amid concerns over the potential rate hikes and other macro headwinds, this has created an attractive opportunity for investors to scoop…

All Australian adults who haven't had a COVID-19 booster or a confirmed case in the past six months are now eligible for an additional shot.

Katie Pritchard is having to crowdfund £200,000 for private treatment after she was twice misdiagnosed, being told her symptoms may have been down to the Pfizer vaccine and even being insulted by the suggestion it was an STI

LOS ANGELES — Black and Latino children in Los Angeles County younger than 5 have COVID-19 vaccination rates in the single digits, reflecting a broad trend nationwide that has public health experts concerned and seeking ways to boost those figures.

The film will follow the lives of five ordinary Welshmen as they go through an extraordinary journey which ultimately, and quite accidentally - led to the creation of the erectile dysfunction drug - Viagra

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…